Neuphoria Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-10,472 |
Gross Profit | -165 | -165 | -250 | -10,472 |
EBITDA | -1,003 | -3,265 | -8,301 | -10,162 |
EBIT | -1,169 | -3,514 | -8,551 | -10,380 |
Net Income | -505 | 2,792 | -14,987 | -14,853 |
Net Change In Cash | 0 | 0 | 0 | -10,472 |
Free Cash Flow | -3,871 | -6,435 | -3,794 | 73,566 |
Cash | 19,440 | 22,170 | 13,649 | 21,591 |
Basic Shares | 5,411 | 4,536 | 2,246 | 1,622 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $15,649 | $0 | $0 | $383 |
Gross Profit | 15,649 | -662 | -671 | 383 |
EBITDA | -121 | -25,651 | -31,452 | -30,251 |
EBIT | -1,129 | -26,644 | -32,450 | -31,864 |
Net Income | -369 | -23,193 | -32,181 | -31,624 |
Net Change In Cash | 15,649 | 0 | 0 | 383 |
Free Cash Flow | 77,229 | -14,681 | -9,846 | -21,754 |
Cash | 21,591 | 12,608 | 8,056 | 33,561 |
Basic Shares | 1,622 | 149,800 | 122,394 | 112,779 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.09 |
2025-12-31 | $0.41 |
2025-09-30 | -$4.41 |
2025-06-30 | -$5.55 |